Health Care: Drugs

Merrimack Pharmaceuticals Inc (MACK: NASDAQ)

$7.29 n/a | n/a%
09/19/14 - 03:59 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 47.79M 48.92M 34.22M 20.30M
Cost of Sales 144.55M 122.19M 96.03M 54.65M
Gross Operating Profit -96.76M -73.27M -61.82M -34.34M
Selling, General, and Administrative Expenses 21.19M 15.80M 14.45M 11.38M
Research & Development 0.00 0.00 0.00 0.00
Operating Income before D & A (EBITDA) -117.95M -89.08M -76.27M -45.73M
Depreciation & Amortization 2.59M 3.66M 4.60M 3.63M
Interest Income 166.00K 184.00K 56.00K 74.00K
Other Income - Net 627.00K 1.36M 1.15M 2.67M
Special Income / Charges 0.00 0.00 0.00 178.00K
Total Income Before Interest Expenses (EBIT) -119.75M -91.20M -79.66M -46.43M
Interest Expense 10.94M 553.00K 13.00K 3.73M
Pre-Tax Income -130.68M -91.75M -79.68M -50.16M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 240.00K -477.00K -453.00K -55.00K
Net Income From Continuing Operations -130.68M -91.75M -79.68M -50.16M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -130.68M -91.75M -79.68M -50.16M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -130.92M -91.28M -79.22M -50.10M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-130.68M -91.75M -79.68M -50.34M
Preferred Dividends
Net Income Available To Common -130.68M -91.75M -79.68M -50.16M
Basic EPS from Continuing Ops. -1.32 -1.25 -6.98 0.00
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.32 -1.25 -6.98 0.00
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 -0.03 -0.69 0.00
Basic EPS, Total -1.32 -1.28 -7.67 0.00
Basic Normalized Net Income/Share -1.32 -1.25 -6.98 n.a.
EPS fr Continuing Ops. -1.32 -1.25 -6.98 0.00
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.32 -1.25 -6.98 0.00
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 -0.03 -0.69 0.00
EPS, Total -1.32 -1.28 -7.67 0.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.32 -1.25 -6.98 n.a.
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with MACK

Latest MACK Headlines from TheStreet

More Financial News for MACK

Press Releases for MACK

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter